FIGURE

Fig. 4

ID

ZDB-FIG-211008-11

Publication

Yu et al., 2021 - Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

GBDP improves 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced cognitive impairment in mice. (A) T-turn time in the pole test on day 19. (B) Site crossings in the morris water maze (MWM) test. (C) GBDP protected dopaminergic neurons in the MPTP-induced mouse model of Parkinson’s disease. Brain sections were processed for HE staining. Black arrow: nerve fiber bundles are loose and lightly stained and the fiber components are significantly reduced; yellow arrow: a large number of neurons were atrophied and the nuclei were intensely stained; green arrow: glial cells show slight hyperplasia. ∗∗P < 0.001. Data were analyzed by unpaired, two-tailed Student’s t-test. n = 5 per group.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Pharm Anal